Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-11

Clinical Trial Update: Adalimumab in Adult Japanese Subjects With Psoriasis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updates evaluate adalimumab in adult Japanese patients with psoriasis, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Psoriasis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2010-01-11